The value proposition of investigator-initiated clinical trials conducted by networks
| dc.contributor.author | Tate, R. | |
| dc.contributor.author | Britton, E. | |
| dc.contributor.author | Webb, S. | |
| dc.contributor.author | Ramage, C. | |
| dc.contributor.author | Bernhardt, J. | |
| dc.contributor.author | Cass, A. | |
| dc.contributor.author | French, C.J. | |
| dc.contributor.author | Groom, K. | |
| dc.contributor.author | Herkes, R. | |
| dc.contributor.author | Katz, C. | |
| dc.contributor.author | Mol, B.W. | |
| dc.contributor.author | Simes, R.J. | |
| dc.contributor.author | Sonderlund, N. | |
| dc.contributor.author | Butcher, B.E. | |
| dc.contributor.author | Zalcberg, J.R. | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Abstract not available | |
| dc.description.statementofresponsibility | Rhiannon Tate, Emma Britton, Steve Webb, Charlotte Ramage, Julie Bernhardt ... Bernardus Mol ... et al. | |
| dc.identifier.citation | Medical Journal of Australia, 2021; 214(4):159-161 | |
| dc.identifier.doi | 10.5694/mja2.50935 | |
| dc.identifier.issn | 0025-729X | |
| dc.identifier.issn | 1326-5377 | |
| dc.identifier.orcid | Mol, B.W. [0000-0001-6887-0262] [0000-0001-8337-550X] | |
| dc.identifier.uri | http://hdl.handle.net/2440/130937 | |
| dc.language.iso | en | |
| dc.publisher | Australasian Medical Publishing Company | |
| dc.relation.grant | http://purl.org/au-research/grants/nhmrc/1176437 | |
| dc.rights | © 2021 The Authors. Medical Journal of Australia published by John Wiley & Sons Australia, Ltd on behalf of AMPCo Pty Ltd This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. | |
| dc.source.uri | https://doi.org/10.5694/mja2.50935 | |
| dc.subject | Clinical trials as topic; cost-benefit analysis; economics; medical | |
| dc.title | The value proposition of investigator-initiated clinical trials conducted by networks | |
| dc.type | Journal article | |
| pubs.publication-status | Published |